Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " August 22, 2007":" September 21, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Bioequivalency Study of Zidovudine Under Fasting Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
2 Completed Bioequivalency Study of Zidovudine Under Fed Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
3 Completed Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults
Condition: HIV Infections
Interventions: Biological: PennVax B;   Biological: IL-12;   Biological: IL-15
4 Completed
Has Results
Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
Condition: HIV Infections
Interventions: Drug: darunavir 800 mg;   Drug: FTC 200 mg/TDF 300mg;   Drug: Maraviroc;   Drug: Raltegravir;   Drug: Ritonavir 100 mg
5 Completed Double Protease Inhibitor to Darunavir Switch Study
Condition: HIV Infections
Intervention: Drug: Darunavir ritonavir
6 Completed Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine
7 Completed Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
Condition: HIV Infections
Intervention: Biological: Biologically active recombinant Tat protein
8 Unknown  A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
Condition: HIV Infections
Intervention: Biological: EP1090
9 Completed A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV
Condition: HIV Infections
Interventions: Behavioral: MBSR group;   Other: Control
10 Completed Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
Condition: HIV Infections
Intervention: Procedure: Infant feeding counseling that includes Flash-heat
11 Completed Integrase Inhibitor (MK-0518) Viral Decay
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK0518);   Drug: Placebo;   Procedure: Leukopheresis;   Procedure: Sigmoid Biopsy
12 Terminated HIV - Monotherapy in Switzerland (MOST-ch)
Condition: HIV Infections
Interventions: Drug: Lopinavir-Monotherapy;   Drug: HAART
13 Completed Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
Condition: HIV Infections
Interventions: Drug: tenofovir + emtricitabine + efavirenz;   Drug: tenofovir + emtricitabine + lopinavir-ritonavir;   Drug: tenofovir + emtricitabine + atazanavir-ritonavir
14 Unknown  HIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
Intervention: Drug: ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz
15 Completed TMC 125 Blood Levels Study
Condition: HIV Infections
Interventions: Drug: TMC125 once daily;   Drug: TMC125 twice daily
16 Completed
Has Results
Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir
17 Completed
Has Results
Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
18 Completed
Has Results
Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects
Condition: HIV Infections
Intervention: Drug: raltegravir
19 Completed Switching From PI to RALtegravir in HIV Stable Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: boosted PI
20 Completed
Has Results
RAL-eve Study: Raltegravir Substitution Study
Condition: HIV Infections
Intervention: Drug: Raltegravir

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.